FDA programs - Breakthrough | Fast track | Accelerated Approval | Priority Review

The FDA has several programs aimed at streamlining and accelerating the development and review of new drugs for the treatment of serious or life-threatening conditions, particularly where there is an unmet medical need The programs include: breakthrough therapy designation, fast track designation, accelerated approval, and priority review and we provide a quick overview about the same. For more details: https://www.fda.gov/regulatory-information/food-and-drug-administration-safety-and-innovation-act-fdasia/frequently-asked-questions-breakthrough-therapies